FDA Investigator Gary Durbiel Goldner
Gary Durbiel Goldner has conducted inspections on 18 sites in 1 countries as of 16 Apr 2012. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
16 Apr 2012
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gary Durbiel Goldner:
Allison M Scheck,
Althea A Williams,
Amy S Graf,
Anthony R Petriella,
Art O Czabaniuk,
Ava M Bowman,
Barbara A Rusin,
Bei Y He,
Benjamin J Dastoli,
Benjamin J Smith,
Bleta Vuniqi,
Brian J Mundo,
Brian M Campbell,
Brian M Marosan,
Bryan J Love,
Calvin K Cook,
Catherine V Quinlan,
CDR Sean T Creighton,
Charles M Spyr,
Christina Eggleston,
Cynthia L Aycock,
David A Paterson,
David J Gasparovich,
Deanna L Lampley,
Dennis R Downer,
Dolores Harper,
Donald W Myrick,
Emest F Bizjak,
Emily J Orban,
Eric S Pittman,
Erma Zaimova,
George G Calafactor,
Gregory A Cronce,
Hokenson,
Jacob A Clark,
James A Lane,
James E Szelc,
Jeffrey A Sommers,
Joseph R Strelnik,
K Gonzlez,
Kimberly Lewandowski Walker,
Kinh Q Mac,
Laureen F Kononen,
Laureen M Geniusz,
Lauren E Burke,
Lauren E Sexton,
LCDR Anastasia M Piliafas Brown,
Lisa J Joseph,
Lisa P Oakes,
Marissa S Steinhagen,
Marlon K Turner,
Martha Sullivan Myrick,
Martin R Vowell,
Matthew J Gretkierewicz,
Meisha R Sampson,
Meisha Waters,
Michael A Moutray,
Michele L Forster, PhD,
Msdap Gonzlezk,
Muna Algharibeh,
Nancy A Bellamy,
Neali H Lucas,
Owens,
Patrick B Cummings,
Rasha Bamieh,
Rebecca E Dombrowski,
Robert M Barbosa,
Robert P Whisenant,
Rosanna M Goodrich,
Ryan J Benedict,
Sara M Onyango,
Sargum C Manley,
Sargum C Sood,
Scott C Gonzalez,
Shannon A Gregory,
Sherri J Jackson,
Sonya M Lambkin,
Suyang Qin,
Talmane J Fisher,
Teresa K Kastner,
Thomas A Peter,
Tracey L Siebesma,
Twana R Chandler,
Vesa Vuniqi,
Victoria A Murray,
William D Tingley,
William R Brubaker
Gary Durbiel Goldner's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more